Pak Fah Yeow International Limited (0239.HK)

HKD 2.27

(-1.3%)

Revenue Summary of Pak Fah Yeow International Limited

  • Pak Fah Yeow International Limited's latest annual revenue in 2023 was 259.15 Million HKD , up 76.06% from previous year.
  • Pak Fah Yeow International Limited's latest quarterly revenue in 2024 Q2 was 132.84 Million HKD , down 0.0% from previous quarter.
  • Pak Fah Yeow International Limited reported a annual revenue of 147.2 Million HKD in annual revenue 2022, up 5.28% from previous year.
  • Pak Fah Yeow International Limited reported a annual revenue of 139.82 Million HKD in annual revenue 2021, up 27.88% from previous year.
  • Pak Fah Yeow International Limited reported a quarterly revenue of 259.15 Million HKD for 2023 FY, up 76.06% from previous quarter.
  • Pak Fah Yeow International Limited reported a quarterly revenue of 132.74 Million HKD for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of Pak Fah Yeow International Limited (2023 - 1999)

Historical Annual Revenue of Pak Fah Yeow International Limited (2023 - 1999)

Year Revenue Revenue Growth
2023 259.15 Million HKD 76.06%
2022 147.2 Million HKD 5.28%
2021 139.82 Million HKD 27.88%
2020 109.34 Million HKD -26.0%
2019 147.76 Million HKD 4.3%
2018 141.66 Million HKD -21.29%
2017 179.98 Million HKD -1.74%
2016 183.15 Million HKD 0.32%
2015 182.57 Million HKD -2.6%
2014 187.45 Million HKD 15.7%
2013 162.01 Million HKD 26.04%
2012 128.54 Million HKD 10.88%
2011 115.93 Million HKD 7.45%
2010 107.88 Million HKD -0.06%
2009 107.95 Million HKD -5.67%
2008 114.44 Million HKD 12.81%
2007 101.45 Million HKD 1.36%
2006 100.09 Million HKD 4.04%
2005 96.2 Million HKD 7.64%
2004 89.38 Million HKD 6.7%
2003 83.77 Million HKD -3.67%
2002 86.96 Million HKD 10.03%
2001 79.03 Million HKD -15.12%
2000 93.1 Million HKD 1.06%
1999 92.13 Million HKD 0.0%

Peer Revenue Comparison of Pak Fah Yeow International Limited

Name Revenue Revenue Difference
Grand Pharmaceutical Group Limited 10.52 Billion HKD 97.539%
Extrawell Pharmaceutical Holdings Limited 59.09 Million HKD -338.522%
Wai Yuen Tong Medicine Holdings Limited 783.88 Million HKD 66.939%
Qianhai Health Holdings Limited 961.29 Million HKD 73.041%
Lee's Pharmaceutical Holdings Limited 1.05 Billion HKD 75.389%
Essex Bio-Technology Limited 1.7 Billion HKD 84.814%
Tongfang Kontafarma Holdings Limited 809.1 Million HKD 67.97%
PuraPharm Corporation Limited 406.85 Million HKD 36.303%
SSY Group Limited 6.46 Billion HKD 95.99%
JBM (Healthcare) Limited 648.41 Million HKD 60.032%
Jacobson Pharma Corporation Limited 1.46 Billion HKD 82.344%
China Resources Pharmaceutical Group Limited 270.39 Billion HKD 99.904%